Early treatment plan for children at risk of nearsightedness
Part of Eyes & vision clinical trials.
This study tests an early intervention for 5-6 year old children who are at risk of developing nearsightedness (myopia). The goal is to see if starting treatment early can prevent or slow down vision problems, which might help your child avoid stronger glasses later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be 5-6 years old (senior kindergarten).
- Child's refractive error (eye prescription) must be between +1.00 and -0.50 diopters in the eye that is more nearsighted.
- Astigmatism (blurred vision due to an irregularly shaped cornea) must be 1.5 diopters or less in both eyes.
- Difference in prescription between the two eyes (anisometropia) must be 1.50 diopters or less.
- Child must have good vision without glasses (6/7.5 or better) in both eyes.
- At least one parent must have moderate nearsightedness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
This trial tests whether a combination of low-dose atropine eye drops (0.02% or 0.04%) and special glasses (called DIMS) can slow down the worsening of moderate to high myopia in children aged 6 to 12.
This study compares different ways to slow down nearsightedness (myopia) in children, including eyedrops and other treatments. It is designed for kids whose vision is getting worse and who are willing to join for 2 years.
This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.